Description
An ω-3 endocannabinoid epoxide and CB receptor agonist (EC50s = 0.43 and 22.5 nM for CB1 and CB2 receptors, respectively); reduces the viability of 143B metastatic osteosarcoma cells at 12.5 and 25 μM; induces apoptosis and inhibits cell migration in a wound-healing assay in 143B, MG63, and HOS osteosarcoma cells; reduces tube formation by HUVECs in a Matrigel™ assay,
Formal name: N-(2-hydroxyethyl)-9-[3-(2Z,5Z,8Z)-2,5,8-undecatrien-1-yl-2-oxiranyl]-4Z,7Z-nonadienamide
Synonyms: 10,11-EDP epoxide|10,11-EDP-EA|10,11-epoxy Docosapentaenoic Ethanolamide
Molecular weight: 387.6
CAS: 2123484-71-7
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Docosanoids||Product Type|Biochemicals|Lipids|Fatty Amides||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research